Prevalence of Neuropathic Pain After Non-instrumented Lumbar Spinal Surgery

NCT06763224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2026-02-06

No results posted yet for this study

Summary

Chronic neuropathic pain following lumbar spine surgery is often under-diagnosed and difficult to relieve. It can persist long after the operation, sometimes for months or even years, and has a major impact on the quality of life of patients who suffer from it. However, the scientific literature on the subject remains relatively poor, as evidenced by the absence of scientific studies on the prevalence of neuropathic pain after lumbar spinal surgery, whether instrumented or not.

The main aim of this study is to determine whether lumbar spine surgery has an impact on the prevalence of neuropathic pain. Participants will be followed up and complete a quality-of-life questionnaire for one year after surgery.

Conditions

  • Lumbar Disc Herniation
  • Lumbar Spinal Stenosis

Interventions

OTHER

Questionnaire and Physical Exam

The neuropathic pain measured with the Neuropathic pain DN4 Questionnaire (Echelle de la Douleur Neuropathique en 4 questions - Neuropathic Pain Scale in 4 questions) The global pain measured with Visual Analogue Scale (VAS) The patient's permanent functional disability measured with the Oswestry disability index (ODI) The quality of life measured with the questionnaire EuroQol-5 Dimension (EQ-5D-5L)

Sponsors & Collaborators

  • Centre Hospitalier de Colmar

    lead OTHER

Principal Investigators

  • Jimmy VOIRIN · Centre Hospitalier de Colmar

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-09-05
Completion
2025-09-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06763224 on ClinicalTrials.gov